Intranasal esketamine effectively treats treatment-resistant depression in adults regardless of baseline irritability.
第一作者:
Manish K,Jha
第一单位:
Center for Depression Research and Clinical Care, University of Texas Southwestern Medical Center, Dallas, TX, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: manish.jha@utsouthwestern.edu.
作者:
医学主题词
人类(Humans);成年人(Adult);鼻用喷雾剂(Nasal Sprays);抑郁(Depression);抗抑郁药(Antidepressive Agents);双盲法(Double-Blind Method);治疗结果(Treatment Outcome)
DOI
10.1016/j.jad.2022.10.020
PMID
36273682
发布时间
2023-02-16
- 浏览0
Journal of affective disorders
153-160页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



